Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 1999

View Archived Issues

Favorable data presented for PEGASYS in HCV therapy

Glaxo Wellcome launches first drug to treat PPH in Japan

ImClone highlights Q1 1999 progress with cancer products

Therapeutic Antibodies reports advances in product development in Q1 1999

Progress in key development programs reported by Cantab

Novel epoxysuccinamide derivatives for bone diseases/arthritis developed at Nippon Chemiphar

Hokuriku Seiyaku claims new thiourea antibacterial agents

Muscarinic antagonists from Tokyo Tanabe particularly useful for respiratory disorders

Merck presents new 8a-azalides and their use in the treatment of bacterial infections

BASF describes new, selective ECE inhibitors

K1-5 is a more potent angiogenesis inhibitor than angiostatin

Tetrahydrofurans as 5-HT2 receptor antagonists: synthesis and preliminary pharmacological evaluation

Novel series from Dr. Reddy for diabetes, hyperlipidemia, etc.

Merck closes in on oral oxytocin antagonist for use in preterm labor

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

Addition of BTI-322 to tacrolimus immunosuppression decreases incidence of transplant rejection

L-770644: potent and selective human beta3-adrenoceptor agonist with good oral bioavailability

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting

SkyePharma announces U.S. launch of DepoCyt

Axcan's Protectaid contraceptive sponge approved in Italy

Abgenix MAb shows promise in GVHD following stem cell transplantation and heads for pivotal trials

Alteon to seek new partner for continued pimagedine development

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

Cortex receives SBIR grant for new stroke therapy

FDA approves Vioxx for osteoarthritis, acute pain and menstrual pain

Adenosine A1 antagonist prevents ischemia-reperfusion injury in the liver

Chinese Kampo medicine is effective and safe in the treatment of bowel obstruction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...